NCT06143748 2025-09-17
EC-CRT-006
Sun Yat-sen University
Phase 2 Active not recruiting
Clinical Trials
9 trialsNCT05520619 2024-11-18
EC-CRT-002
Sun Yat-sen University
Phase 2 Active not recruiting
NCT06588335 2024-09-19
BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Henan Provincial People's Hospital
Phase 2 Not yet recruiting
NCT04005170 2022-08-23
Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer
Sun Yat-sen University
Phase 2 Completed
NCT04625543 2022-04-26
Neoadjuvant Immunotherapy to ESCC
Qilu Hospital of Shandong University
Phase 2 Withdrawn
NCT04006041 2019-12-26
Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT03927495 2019-05-29
KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital
Phase 2 Unknown
NCT02133612 2015-04-14
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase 2 Completed
NCT01444547 2014-05-06
A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin
ChineseAMS
Phase 2 Unknown